The WACC of Tarsus Pharmaceuticals, Inc. (TARS) is 6.6%.
| Range | Selected | |
| Cost of equity | 5.40% - 7.80% | 6.60% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 7.00% - 7.00% | 7.00% |
| WACC | 5.4% - 7.7% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.33 | 0.52 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 5.40% | 7.80% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.02 | 0.02 |
| Cost of debt | 7.00% | 7.00% |
| After-tax WACC | 5.4% | 7.7% |
| Selected WACC | 6.6% | |